LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 69.06 | 17.25 | 9268 | 5242 | 1.7678 | 1.1430 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 69.06 | 17.25 | 13 | 5242 | 0.0025 | -0.0337 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 69.06 | 17.25 | 10046 | 5242 | 1.9162 | 1.1641 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 71.03 | 17.25 | 14 | 5367 | 0.0026 | -0.0249 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 71.03 | 17.25 | 9785 | 5367 | 1.8232 | 1.1504 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 71.03 | 17.25 | 5 | 5367 | 0.0009 | -0.1389 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 71.03 | 17.25 | 10443 | 5367 | 1.9458 | 1.1674 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 73.00 | 17.25 | 15 | 5546 | 0.0027 | -0.0167 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 73.00 | 17.25 | 10280 | 5546 | 1.8533 | 1.1538 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 73.00 | 17.25 | 6 | 5546 | 0.0011 | -0.1191 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 73.00 | 17.25 | 10862 | 5546 | 1.9582 | 1.1681 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 74.97 | 17.25 | 20 | 5618 | 0.0036 | 0.0179 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 74.97 | 17.25 | 10751 | 5618 | 1.9134 | 1.1617 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 74.97 | 17.25 | 12 | 5618 | 0.0021 | -0.0426 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 74.97 | 17.25 | 11186 | 5618 | 1.9908 | 1.1720 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 76.94 | 17.25 | 16 | 5681 | 0.0028 | -0.0090 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 76.94 | 17.25 | 11030 | 5681 | 1.9413 | 1.1651 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 76.94 | 17.25 | 8 | 5681 | 0.0014 | -0.0878 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 76.94 | 17.25 | 11507 | 5681 | 2.0253 | 1.1761 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 78.91 | 17.25 | 17 | 5730 | 0.0030 | -0.0018 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 78.91 | 17.25 | 11285 | 5730 | 1.9693 | 1.1685 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 78.91 | 17.25 | 7 | 5730 | 0.0012 | -0.1021 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 78.91 | 17.25 | 11770 | 5730 | 2.0539 | 1.1795 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 80.88 | 17.25 | 19 | 5826 | 0.0033 | 0.0116 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 80.88 | 17.25 | 11517 | 5826 | 1.9768 | 1.1690 | MN20160310_N02 | D17 |